Cellular neuroprotection as a modern treatment approach for optic neuropathy

Aim. To develop technology to create 3D-spheroid multipotent mesenchymal stem cells (MMSC) of limbal cadaveric human eyes, capable of safe and long-term secretion of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF).Materials and methods. MMSC were obtained by cultivation of lim...

Full description

Saved in:
Bibliographic Details
Main Authors: S. A. Borzenok, M. Kh. Khubetsova, I. N. Saburina, N. A. Gavrilova, Kh. D. Tonaeva, D. S. Ostrovskiy, N. I. Lanevskaya, N. V. Kosheleva, I. M. Zurina
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2017-04-01
Series:Вестник трансплантологии и искусственных органов
Subjects:
Online Access:https://journal.transpl.ru/vtio/article/view/735
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849242356748910592
author S. A. Borzenok
M. Kh. Khubetsova
I. N. Saburina
N. A. Gavrilova
Kh. D. Tonaeva
D. S. Ostrovskiy
N. I. Lanevskaya
N. V. Kosheleva
I. M. Zurina
author_facet S. A. Borzenok
M. Kh. Khubetsova
I. N. Saburina
N. A. Gavrilova
Kh. D. Tonaeva
D. S. Ostrovskiy
N. I. Lanevskaya
N. V. Kosheleva
I. M. Zurina
author_sort S. A. Borzenok
collection DOAJ
description Aim. To develop technology to create 3D-spheroid multipotent mesenchymal stem cells (MMSC) of limbal cadaveric human eyes, capable of safe and long-term secretion of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF).Materials and methods. MMSC were obtained by cultivation of limbal fragments, released from cadaveric donor human eye. Cultivation was carried out in DMEM/F12 medium, supplemented with L-glutamine, penicillin, streptomycin, amphotericin B, HEPES, insulin, dexamethasone and 10 vol.% FBS under standard conditions (5% СО2, 37 °C), medium change was performed every 3 days. To determine the phenotype of the received cell culture the method of immunophenotyping by marker proteins to MMSC (CD73, CD105, CD19, CD90, CD133) was used. Stimulation of neurotrophic factor secretion was performed via a twostep procedure. 3D-cell spheroids were created with the help of agarous plates for three groups of comparison, where group I was control group, spheroids of intact 2D-culture MMSK; group II – spheroids of previously induced 2D-culture MMSC; group III – spheroids of 2D-MMSC induced on the 1st day of cultivation. Cell cultures supernatants were selected in different periods for NGF and BDNF follow-up study by ELISA procedure.Results. Induction of 3D-spheroids of limbal MMSC promotes short-term increase of the level of BDNF and NGF, but further, the secretion of these factors significantly decreases. Induction leads to a change in the morphology of spheroids: loss of compactness and emergence of «fringed» (debris). Such changes indicate of frailty of received constructions. Spheroids from previously induced MMSC are capable of stable NTF secretion, but the level of secretion is much less as compared to the control group.Conclusion. 3D-cell culture of intact 2Dculture of limbal MMSC can be considered as cellular medication for a safe and long-term neuroprotection in optic neuropathy treatment.
format Article
id doaj-art-35dd385ae600405daafc483f3993873d
institution Kabale University
issn 1995-1191
language Russian
publishDate 2017-04-01
publisher Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
record_format Article
series Вестник трансплантологии и искусственных органов
spelling doaj-art-35dd385ae600405daafc483f3993873d2025-08-20T03:59:52ZrusFederal Research Center of Transplantology and Artificial Organs named after V.I.ShumakovВестник трансплантологии и искусственных органов1995-11912017-04-01191637310.15825/1995-1191-2017-1-63-73607Cellular neuroprotection as a modern treatment approach for optic neuropathyS. A. Borzenok0M. Kh. Khubetsova1I. N. Saburina2N. A. Gavrilova3Kh. D. Tonaeva4D. S. Ostrovskiy5N. I. Lanevskaya6N. V. Kosheleva7I. M. Zurina8The S.N. Fyodorov Eye Microsurgery Complex of the Ministry of Healthcare of Russian Federation A.I. Evdokimov Moscow State University of Medicine and DentistryThe S.N. Fyodorov Eye Microsurgery Complex of the Ministry of Healthcare of Russian FederationThe Institute of General Pathology and Pathophysiology Russian Medical Academy of Postgraduate Education StudiesA.I. Evdokimov Moscow State University of Medicine and DentistryThe S.N. Fyodorov Eye Microsurgery Complex of the Ministry of Healthcare of Russian FederationThe S.N. Fyodorov Eye Microsurgery Complex of the Ministry of Healthcare of Russian FederationThe S.N. Fyodorov Eye Microsurgery Complex of the Ministry of Healthcare of Russian Federation A.I. Evdokimov Moscow State University of Medicine and DentistryThe Institute of General Pathology and PathophysiologyThe Institute of General Pathology and PathophysiologyAim. To develop technology to create 3D-spheroid multipotent mesenchymal stem cells (MMSC) of limbal cadaveric human eyes, capable of safe and long-term secretion of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF).Materials and methods. MMSC were obtained by cultivation of limbal fragments, released from cadaveric donor human eye. Cultivation was carried out in DMEM/F12 medium, supplemented with L-glutamine, penicillin, streptomycin, amphotericin B, HEPES, insulin, dexamethasone and 10 vol.% FBS under standard conditions (5% СО2, 37 °C), medium change was performed every 3 days. To determine the phenotype of the received cell culture the method of immunophenotyping by marker proteins to MMSC (CD73, CD105, CD19, CD90, CD133) was used. Stimulation of neurotrophic factor secretion was performed via a twostep procedure. 3D-cell spheroids were created with the help of agarous plates for three groups of comparison, where group I was control group, spheroids of intact 2D-culture MMSK; group II – spheroids of previously induced 2D-culture MMSC; group III – spheroids of 2D-MMSC induced on the 1st day of cultivation. Cell cultures supernatants were selected in different periods for NGF and BDNF follow-up study by ELISA procedure.Results. Induction of 3D-spheroids of limbal MMSC promotes short-term increase of the level of BDNF and NGF, but further, the secretion of these factors significantly decreases. Induction leads to a change in the morphology of spheroids: loss of compactness and emergence of «fringed» (debris). Such changes indicate of frailty of received constructions. Spheroids from previously induced MMSC are capable of stable NTF secretion, but the level of secretion is much less as compared to the control group.Conclusion. 3D-cell culture of intact 2Dculture of limbal MMSC can be considered as cellular medication for a safe and long-term neuroprotection in optic neuropathy treatment.https://journal.transpl.ru/vtio/article/view/735optic neuropathylimbal multipotent mesenchymal stem cells3d-culturecellular spheroidsnerve growth factor (ngf)brain-derived neurotrophic factor (bdnf)cell therapyneuroprotection
spellingShingle S. A. Borzenok
M. Kh. Khubetsova
I. N. Saburina
N. A. Gavrilova
Kh. D. Tonaeva
D. S. Ostrovskiy
N. I. Lanevskaya
N. V. Kosheleva
I. M. Zurina
Cellular neuroprotection as a modern treatment approach for optic neuropathy
Вестник трансплантологии и искусственных органов
optic neuropathy
limbal multipotent mesenchymal stem cells
3d-culture
cellular spheroids
nerve growth factor (ngf)
brain-derived neurotrophic factor (bdnf)
cell therapy
neuroprotection
title Cellular neuroprotection as a modern treatment approach for optic neuropathy
title_full Cellular neuroprotection as a modern treatment approach for optic neuropathy
title_fullStr Cellular neuroprotection as a modern treatment approach for optic neuropathy
title_full_unstemmed Cellular neuroprotection as a modern treatment approach for optic neuropathy
title_short Cellular neuroprotection as a modern treatment approach for optic neuropathy
title_sort cellular neuroprotection as a modern treatment approach for optic neuropathy
topic optic neuropathy
limbal multipotent mesenchymal stem cells
3d-culture
cellular spheroids
nerve growth factor (ngf)
brain-derived neurotrophic factor (bdnf)
cell therapy
neuroprotection
url https://journal.transpl.ru/vtio/article/view/735
work_keys_str_mv AT saborzenok cellularneuroprotectionasamoderntreatmentapproachforopticneuropathy
AT mkhkhubetsova cellularneuroprotectionasamoderntreatmentapproachforopticneuropathy
AT insaburina cellularneuroprotectionasamoderntreatmentapproachforopticneuropathy
AT nagavrilova cellularneuroprotectionasamoderntreatmentapproachforopticneuropathy
AT khdtonaeva cellularneuroprotectionasamoderntreatmentapproachforopticneuropathy
AT dsostrovskiy cellularneuroprotectionasamoderntreatmentapproachforopticneuropathy
AT nilanevskaya cellularneuroprotectionasamoderntreatmentapproachforopticneuropathy
AT nvkosheleva cellularneuroprotectionasamoderntreatmentapproachforopticneuropathy
AT imzurina cellularneuroprotectionasamoderntreatmentapproachforopticneuropathy